---
document_datetime: 2025-06-02 12:30:27
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/opdivo-epar-all-authorised-presentations_en.pdf
document_name: opdivo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9975765
conversion_datetime: 2025-12-24 23:37:35.338009
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number        | Invented name   | Strength   | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Content          | Pack size   |
|------------------|-----------------|------------|---------------------------------------|---------------------------|-----------------------|------------------|-------------|
| EU/1/15/1014/001 | OPDIVO          | 10 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 4 ml             | 1 vial      |
| EU/1/15/1014/002 | OPDIVO          | 10 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 10 ml            | 1 vial      |
| EU/1/15/1014/003 | OPDIVO          | 10 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 24 ml            | 1 vial      |
| EU/1/15/1014/004 | OPDIVO          | 10 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 12 ml            | 1 vial      |
| EU/1/15/1014/005 | OPDIVO          |            | Solution for injection                | Subcutaneous use          | vial (glass)          | 5 ml (120 mg/ml) | 1 vial      |